Jinming Yu

836 total citations
44 papers, 615 citations indexed

About

Jinming Yu is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jinming Yu has authored 44 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 28 papers in Pulmonary and Respiratory Medicine and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jinming Yu's work include Esophageal Cancer Research and Treatment (30 papers), Lung Cancer Diagnosis and Treatment (20 papers) and Gastric Cancer Management and Outcomes (12 papers). Jinming Yu is often cited by papers focused on Esophageal Cancer Research and Treatment (30 papers), Lung Cancer Diagnosis and Treatment (20 papers) and Gastric Cancer Management and Outcomes (12 papers). Jinming Yu collaborates with scholars based in China, United States and United Kingdom. Jinming Yu's co-authors include Xue Meng, Li Kong, Dianbin Mu, Zheng Fu, Fen Zhao, Minghuan Li, Baijiang Zhang, Wei Huang, Zicheng Zhang and Tao Zhou and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Advanced Energy Materials.

In The Last Decade

Jinming Yu

39 papers receiving 602 citations

Peers

Jinming Yu
W. Burrows United States
Qiao-Qiao Li China
Emmanuel Rio France
Cheng‐Hsiang Lo Taiwan
Juan Martin Magsanoc United States
Baijiang Zhang China
Kaixian Zhang China
Karel Odrážka Czechia
Hidehiro Hojo Japan
Yoshiomi Hatayama Japan
W. Burrows United States
Jinming Yu
Citations per year, relative to Jinming Yu Jinming Yu (= 1×) peers W. Burrows

Countries citing papers authored by Jinming Yu

Since Specialization
Citations

This map shows the geographic impact of Jinming Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinming Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinming Yu more than expected).

Fields of papers citing papers by Jinming Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinming Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinming Yu. The network helps show where Jinming Yu may publish in the future.

Co-authorship network of co-authors of Jinming Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinming Yu. A scholar is included among the top collaborators of Jinming Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinming Yu. Jinming Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Whang, Grace, Jinming Yu, Christopher Choi, et al.. (2025). Do Micropower Sources Meet the Needs of the Internet of Things?. Advanced Energy Materials. 15(48).
2.
Zhang, Nan, et al.. (2025). The Impact of Multidisciplinary Team Meetings on the Survival of Stage IV NSCLC Patients. Cancer Medicine. 14(21). e71350–e71350.
3.
Yu, Jinming, Mingzhu Liu, Mingming Zhao, et al.. (2025). Galla Chinensis as an antiviral agent: Targeting Micropterus salmoides rhabdovirus infection. Fish & Shellfish Immunology. 167. 110675–110675.
4.
Zhang, Nan, Xinyue Xu, Lu Zhang, et al.. (2025). Development of A Caregiver‐Reported Scale for Pediatric Cancer Financial Toxicity (CRS‐PCFT). Cancer Medicine. 14(4). e70675–e70675. 1 indexed citations
5.
Zhu, Kunli, Jing Fan, Changchun Zhou, et al.. (2025). The highly expressed GOLPH3 in colorectal cancer cells activates smoothened to drive glycolysis and promote cancer cell growth and radiotherapy resistance. Journal of Gastrointestinal Oncology. 16(2). 415–434.
6.
Cai, Guangyan, Kai Wang, Jun Zhao, et al.. (2024). Neoadjuvant Camrelizumab Combined with Chemotherapy for Resectable Stage IIIA-IIIB Non-Small Cell Lung Cancer: Single Arm Phase II Study. International Journal of Radiation Oncology*Biology*Physics. 120(2). e10–e10. 1 indexed citations
7.
Yu, Jinming, et al.. (2022). Treatment-related lymphopenia impairs the treatment response of anti-PD-1 therapy in esophageal squamous cell carcinoma. International Immunopharmacology. 106. 108623–108623. 7 indexed citations
8.
9.
Zhao, Kaikai, et al.. (2020). Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis. Radiation Oncology. 15(1). 243–243. 10 indexed citations
10.
Han, Dali, Guifang Zhang, Lili Wang, et al.. (2019). Subclinical Lesions of the Primary Clinical Target Volume Margin in Esophageal Squamous Cell Carcinoma and Association With FDG PET/CT. Frontiers in Oncology. 9. 336–336. 1 indexed citations
11.
Li, Minghuan, Xiaoli Zhang, Fen Zhao, et al.. (2016). Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice. Radiation Oncology. 11(1). 18–18. 35 indexed citations
12.
Zhao, Fen, Minghuan Li, Zhiheng Wang, et al.. (2015). 18F-Fluorothymidine PET-CT for Resected Malignant Gliomas before Radiotherapy: Tumor Extent according to Proliferative Activity Compared with MRI. PLoS ONE. 10(3). e0118769–e0118769. 13 indexed citations
13.
Xu, Long, et al.. (2015). Computed Tomography–Based Distribution of Involved Lymph Nodes in Patients with Upper Esophageal Cancer. Current Oncology. 22(3). 178–182. 10 indexed citations
14.
15.
Ge, Hong, et al.. (2014). ERCC1 expression and tumor regression predict survival in esophageal squamous cell carcinoma patients receiving combined trimodality therapy. Pathology - Research and Practice. 210(10). 656–661. 10 indexed citations
16.
Yin, Yong, Jinhu Chen, Ligang Xing, et al.. (2011). Applications of IMAT in cervical esophageal cancer radiotherapy: a comparison with fixed‐field IMRT in dosimetry and implementation. Journal of Applied Clinical Medical Physics. 12(2). 48–57. 18 indexed citations
17.
Huang, Wei, Baosheng Li, Heyi Gong, et al.. (2010). Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: A report of 1077 cases. Radiotherapy and Oncology. 95(2). 229–233. 62 indexed citations
18.
Han, Dali, Jinming Yu, Yonghua Yu, et al.. (2009). Comparison of 18F-Fluorothymidine and 18F-Fluorodeoxyglucose PET/CT in Delineating Gross Tumor Volume by Optimal Threshold in Patients With Squamous Cell Carcinoma of Thoracic Esophagus. International Journal of Radiation Oncology*Biology*Physics. 76(4). 1235–1241. 56 indexed citations
19.
Xie, Li, Xianrang Song, Jinming Yu, et al.. (2009). Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs. Journal of Experimental & Clinical Cancer Research. 28(1). 68–68. 23 indexed citations
20.
Yu, Jinming, Baijiang Zhang, Dianbin Mu, et al.. (2008). Using 18F-Fluorodeoxyglucose Positron Emission Tomography to Estimate the Length of Gross Tumor in Patients With Squamous Cell Carcinoma of the Esophagus. International Journal of Radiation Oncology*Biology*Physics. 73(1). 136–141. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Burrows Breakdown of academic impact, for papers by Qiao-Qiao Li Breakdown of academic impact, for papers by Emmanuel Rio Breakdown of academic impact, for papers by Cheng‐Hsiang Lo Breakdown of academic impact, for papers by Juan Martin Magsanoc Breakdown of academic impact, for papers by Baijiang Zhang Breakdown of academic impact, for papers by Kaixian Zhang Breakdown of academic impact, for papers by Karel Odrážka Breakdown of academic impact, for papers by Hidehiro Hojo Breakdown of academic impact, for papers by Yoshiomi Hatayama
Rankless by CCL
2026